171 related articles for article (PubMed ID: 2190395)
1. Clinical correlations with cyclosporine blood levels after allogeneic bone marrow transplantation: an analysis of four different assays.
Atkinson K; Downs K; Ashby M; Biggs J
Transplant Proc; 1990 Jun; 22(3):1331-4. PubMed ID: 2190395
[No Abstract] [Full Text] [Related]
2. Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
Slavin S; Or R; Naparstek E; Weiss L; Mumcuoglu M; Weshler Z; Brautbar H; Cividalli G; Glikson M; Hale G
Transplant Proc; 1987 Feb; 19(1 Pt 3):2614-5. PubMed ID: 3274569
[No Abstract] [Full Text] [Related]
3. Liver transplantation in Birmingham--use of cyclosporine--clinical correlations with drug measurements.
Gunson BK; Jones SR; Buckels JA; Jain AB; McMaster P
Transplant Proc; 1990 Jun; 22(3):1312-8. PubMed ID: 2349692
[No Abstract] [Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic studies of cyclosporine in bone marrow transplantation.
Yee GC
Transplant Proc; 1990 Jun; 22(3):1327-30. PubMed ID: 2190394
[No Abstract] [Full Text] [Related]
5. Bone marrow transplantation: past experiences and future prospects.
Thomas ED
Semin Oncol; 1992 Jun; 19(3 Suppl 7):3-6. PubMed ID: 1615331
[No Abstract] [Full Text] [Related]
6. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
[TBL] [Abstract][Full Text] [Related]
7. Cyclophilin binding: a receptor-mediated approach to monitoring cyclosporine immunosuppressive activity following organ transplantation.
Lorber MI; Paul K; Harding MW; Handschumacher RE; Marks WH
Transplant Proc; 1990 Jun; 22(3):1240-4. PubMed ID: 2190386
[No Abstract] [Full Text] [Related]
8. Japanese conference on cyclosporine blood level monitoring.
Takagi H; Uchida K
Transplant Proc; 1990 Jun; 22(3):1224-5. PubMed ID: 2190384
[No Abstract] [Full Text] [Related]
9. Peripheral blood chemiluminescence as an early indicator of successful bone marrow transplantation.
Toivanen A; Nikoskelainen J; Lilius EM; Salmi TT; Kätkä K; Pelliniemi TT; Mäki AL; Rajamäki A
Transplant Proc; 1987 Feb; 19(1 Pt 3):2745-6. PubMed ID: 3079095
[No Abstract] [Full Text] [Related]
10. Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias.
Mrsić M; Labar B; Bogdanić V; Nemet D; Pavletić Z; Plavsić F; Dobrić I; Kastelan A; Marusić M; Zupancić-Salek S
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():95-6. PubMed ID: 2697416
[No Abstract] [Full Text] [Related]
11. Herpes virus immunity and acute graft-versus-host disease.
Gratama JW; Weiland HT; Hekker AC; Weijers TF; The TH; Stijnen T; Zwaan FE; Vossen JM
Transplant Proc; 1987 Feb; 19(1 Pt 3):2680-2. PubMed ID: 2856285
[No Abstract] [Full Text] [Related]
12. HLA-DP matching in allogeneic bone marrow transplantation.
Pawelec G; Ehninger G; Schmidt H; Rehbein A; Balko I; Wernet P
Transplant Proc; 1987 Feb; 19(1 Pt 3):2741-3. PubMed ID: 3274584
[No Abstract] [Full Text] [Related]
13. Clinical evaluation and therapeutic range of cyclosporine A as monitored by FPIA in kidney transplantation.
Nattermann U; Steimer W; Gokel JM; Seidel D; Land W
Transplant Proc; 1990 Jun; 22(3):1284-6. PubMed ID: 2190391
[No Abstract] [Full Text] [Related]
14. Low incidence of severe acute and chronic graft-versus-host disease as a result of prolonged cyclosporine prophylaxis and early aggressive treatment with corticosteroids.
Ruutu T; Volin L; Elonen E
Transplant Proc; 1988 Jun; 20(3):491-3. PubMed ID: 3289191
[No Abstract] [Full Text] [Related]
15. French multicentre study: comparison of two specific and four nonspecific methods for Sandimmune (cyclosporine) blood and plasma (separated at 37 degrees C or at 22 degrees C) monitoring.
Vernillet L; Humbert H; Aupetit B; Berard M; Bertault-Peres P; Billaud E; Bizollon CA; Breteau M; Brisson AM; Codet JP
Transplant Proc; 1990 Jun; 22(3):1218-23. PubMed ID: 2190383
[No Abstract] [Full Text] [Related]
16. Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.
Sridhar N; Schroeder TJ; Pesce AJ; First MR
Transplant Proc; 1990 Jun; 22(3):1257-9. PubMed ID: 2190387
[No Abstract] [Full Text] [Related]
17. Controlled trial of orally administered immunoglobulin following bone marrow transplantation.
Copelan EA; Bechtel TP; Klein JP; Klein JL; Tutschka P; Kapoor N; Featheringham NC; Avalos BR
Bone Marrow Transplant; 1994 Jan; 13(1):87-91. PubMed ID: 7517256
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of cyclosporine monitoring in renal transplantation.
Lindholm A
Transplant Proc; 1990 Jun; 22(3):1260-3. PubMed ID: 2190388
[No Abstract] [Full Text] [Related]
19. [Cyclosporine in allogeneic bone marrow transplantation in children].
Kojima S; Fukuda M; Horibe K; Matsuyama K
Rinsho Ketsueki; 1987 Sep; 28(9):1576-82. PubMed ID: 3325658
[No Abstract] [Full Text] [Related]
20. An evaluation of cyclosporine monitoring by nonselective fluorescence polarization immunoassay.
Pesce AJ; Schroeder TJ; First MR
Transplant Proc; 1990 Jun; 22(3):1171-4. PubMed ID: 2190376
[No Abstract] [Full Text] [Related]
[Next] [New Search]
